The results showed that there was a significant increase in the expression level of both hepatic miRNA-6881-5P and hepatic Inc-SPARCL1-1:2 in NASH animals, compared to normal controls. This evidence concerns the gene SPARCL1 and metabolic dysfunction-associated steatohepatitis.